LRRK2 is reduced in Parkinson’s disease gut

被引：0
|
作者：
Adrien de Guilhem de Lataillade
Jérémy Verchere
Thibauld Oullier
Alice Prigent
Tony Durand
Carolina Pellegrini
Michel Neunlist
Thierry Baron
Malvyne Rolli-Derkinderen
Pascal Derkinderen
机构：
[1] Université de Nantes,Department of Neurology
[2] Inserm,French Agency for Food, Environmental, and Occupational Health and Safety (ANSES)
[3] TENS,Department of Pharmacy
[4] The Enteric Nervous System in Gut and Brain Diseases,undefined
[5] IMAD,undefined
[6] CHU Nantes,undefined
[7] Inserm U1235 Nantes,undefined
[8] University of Lyon,undefined
[9] University of Pisa,undefined
来源：
Acta Neuropathologica | 2021年 / 142卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：601 / 603
页数：2
相关论文
共 50 条
  • [31] Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2
    Belluzzi, Elisa
    Greggio, Elisa
    Piccoli, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1111 - 1116
  • [32] Development of LRRK2 Kinase Inhibitors for Parkinson's Disease
    Galatsis, Paul
    Henderson, Jaclyn
    Kormos, Bethany L.
    Hirst, Warren D.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 43 - 58
  • [33] Genetics in Parkinson's disease -: the role of LRRK2 mutations
    Toft, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (01): : 70 - 70
  • [34] The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease
    Singleton, Andrew B.
    Gasser, Thomas
    MOVEMENT DISORDERS, 2020, 35 (04) : 551 - 554
  • [35] LRRK2 pathobiology in Parkinson's disease - virtual inclusion
    Martin, Ian
    Kim, Jungwoo Wren
    Dawson, Valina L.
    Dawson, Ted M.
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 75 - 76
  • [36] LRRK2 links genetic and sporadic Parkinson's disease
    Kluss, Jillian H.
    Mamais, Adamantios
    Cookson, Mark R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2019, 47 : 651 - 661
  • [37] LRRK2 screening in a Canadian Parkinson's disease cohort
    Grimes, D. A.
    Racacho, L.
    Han, F.
    Panisset, M.
    Bulman, D. E.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (03) : 336 - 338
  • [38] LRRK2 in Parkinson's disease and dementia with Lewy bodies
    Zhu, Xiongwei
    Babar, Asim
    Siedlak, Sandra L.
    Yang, Qiwei
    Ito, Genta
    Iwatsubo, Takeshi
    Smith, Mark A.
    Perry, George
    Chen, Shu G.
    MOLECULAR NEURODEGENERATION, 2006, 1 (1)
  • [39] A study of LRRK2 mutations and Parkinson's disease in Brazil
    Pimentel, M. M. G.
    Moura, K. C. V.
    Abdalla, C. B.
    Pereira, J. S.
    Rosso, A. L. Z.
    Nicaretta, D. H.
    Campos, M., Jr.
    Almeida, R. M.
    Santos, J. M.
    Bastos, I. C. G.
    Mendes, M. F. X.
    Maultasch, H.
    Costa, F. H. R.
    Werneck, A. L. S.
    Santos-Reboucas, C. B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S41 - S41
  • [40] The Upshot of LRRK2 Inhibition to Parkinson’s Disease Paradigm
    A. R. Esteves
    M. G-Fernandes
    D. Santos
    C. Januário
    S. M. Cardoso
    Molecular Neurobiology, 2015, 52 : 1804 - 1820
12345